2021-11-08T17:39:31-06:00 2021-06-30 953001179 WINDES INC PO BOX 87 LONG BEACH CA 908010087 990 2020-07-01 330841281 PANCREATIC CANCER ACTION NETWORK INC PANC 3107250025 1500 ROSECRANS AVENUE NO 200 MANHATTAN BEACH CA 90266 JULIE FLESHMAN PRESIDENT AND CEO 3107250025 2021-11-02 1 JULIE FLESHMAN 999009999 DONITA M JOSEPH P00286656 5624351191 2021-10-14 2 AAL1 IAL1 2020 2022-09-23 18:48:47Z JULIE FLESHMAN 1500 ROSECRANS AVENUE NO 200 MANHATTAN BEACH CA 90266 59046636 0 X WWW.PANCAN.ORG X 1999 CA TO ADVANCE RESEARCH, SUPPORT PATIENTS, AND CREATE HOPE FOR PEOPLE WHO HAVE PANCREATIC CANCER. 14 13 170 2400 0 0 35529596 36292699 1187016 7330463 1140228 1457324 -1219565 -227948 36637275 44852538 6003848 3229138 0 0 18638131 18772145 0 0 4559335 17682654 18885336 42324633 40886619 -5687358 3965919 60854270 68087532 17601640 18599627 43252630 49487905 X OUR MISSION IS TO TAKE BOLD ACTION TO IMPROVE THE LIVES OF EVERYONE IMPACTED BY PANCREATIC CANCER BY ADVANCING SCIENTIFIC RESEARCH, BUILDING COMMUNITY, SHARING KNOWLEDGE, AND ADVOCATING FOR PATIENTS. 0 0 21883880 3229138 7330463 RESEARCH - PANCAN FUNDS GROUND BREAKING RESEARCH INITIATIVES THAT WILL TRANSFORM THE WAY PANCREATIC CANCER IS DETECTED AND TREATED. WE FUND RESEARCH GRANTS TO INDIVIDUAL INVESTIGATORS AND LARGE-SCALE, MULTI-INSTITUTIONAL CLINICAL PROJECTS THAT ARE FOCUSED ON ADVANCING NEW TREATMENTS AND EARLY DETECTION FOR PANCREATIC CANCER. WE INVESTED A RECORD $22 MILLION IN RESEARCH IN FISCAL YEAR 2021. RESEARCH FUNDING THAT SUPPORTED IMPORTANT RESEARCH PROJECTS AT INSTITUTIONS ACROSS THE COUNTRY, AND PANCAN'S PRECISION PROMISE ADAPTIVE CLINICAL TRIAL, EARLY DETECTION INITIATIVE, KNOW YOUR TUMOR PRECISION MEDICINE SERVICE, AND PATIENT REGISTRY. SINCE 2003, WE'VE AWARDED 218 RESEARCH GRANTS TO 203 SCIENTISTS AT 75 INSTITUTIONS. PANCAN'S CUMULATIVE RESEARCH INVESTMENT IS NOW MORE THAN $149 MILLION, MAKING A SIGNIFICANT IMPACT ON THE DIAGNOSIS, TREATMENT AND CARE OF TODAY'S PATIENTS AND THOSE WHO WILL BE DIAGNOSED IN THE FUTURE. 1327578 GOVERNMENT AFFAIRS AND ADVOCACY - WE DRIVE LEGISLATIVE SUPPORT FOR INCREASED FEDERAL RESEARCH FUNDING FOR PANCREATIC CANCER. OUR GRASSROOTS ADVOCACY EFFORTS LED TO THE PASSAGE OF THE RECALCITRANT CANCER RESEARCH ACT, INCREASED RESEARCH DOLLARS FOR PANCREATIC CANCER AT THE NATIONAL CANCER INSTITUTE, AND LED TO A NEW PANCREATIC CANCER RESEARCH PROGRAM AT THE DEPARTMENT OF DEFENSE. SINCE OUR FOUNDING, FEDERAL RESEARCH FUNDING FOR PANCREATIC CANCER HAS INCREASED BY 900 PERCENT AND CONTINUES TO INCREASE EACH YEAR DUE TO OUR EFFORTS. 3908100 PATIENT SERVICES - PROVIDES FREE, PERSONALIZED INFORMATION AND RESOURCES ABOUT PANCREATIC CANCER, TREATMENT OPTIONS, CLINICAL TRIALS, DIET AND NUTRITION, SPECIALISTS AND SUPPORT RESOURCES TO HELP PATIENTS, CAREGIVERS AND HEALTHCARE PROVIDERS. WE HAVE THE LARGEST, MOST UP-TO-DATE CLINICAL TRIALS DATABASE IN THE COUNTRY AND PROVIDE CONSTITUTENTS WITH PERSONALIZED SEARCHES SO THAT THEY UNDERSTAND ALL OF THEIR TREATMENT OPTIONS. OUR EXPERT PATIENT SERVICES CASE MANAGERS SHARE MORE RESOURCES AND SPEAK WITH MORE PANCREATIC CANCER PATIENTS THAN ANY OTHER ORGANIZATION IN THE WORLD. LAST YEAR ALONE, WE HAD OVER 45,000 INTERACTIONS WITH PANCREATIC CANCER PATIENTS AND FAMILIES. 5816074 COMMUNITY ENGAGEMENT - 57 VOLUNTEER-LED AFFILIATES WITH OVER 2,400 VOLUNTEERS RAISE FUNDS, AWARENESS OF PANCAN AND THE DISEASE, AND EDUCATE THEIR COMMUNITIES ABOUT PANCREATIC CANCER. VOLUNTEERS HOST 58 PURPLESTRIDE FUNDRAISING EVENTS ACROSS THE COUNTRY THIS PAST YEAR, OVER 24,400 PARTICIPANTS REGISTERED AND RAISED OVER $9.3 MILLION. IN ADDITION, INDIVIDUALS HOSTING WAGE HOPE MY WAY EVENTS IN THEIR COMMUNITIES RAISED OVER $4.5 MILLION. WE ARE ALSO A FOUNDING MEMBER OF THE WORLD PANCREATIC CANCER COALITION, COMPRISING MORE THAN 90 PANCREATIC CANCER PATIENT ADVOCACY GROUPS FROM OVER 30 COUNTRIES AND SIX CONTINENTS. THE COALITION HOSTS WORLD PANCREATIC CANCER DAY EVERY NOVEMBER TO RAISE GLOBAL AWARENESS OF THE DISEASE. 5816074 32935632 1 1 0 1 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 64 0 1 170 1 0 0 0 0 0 0 0 0 0 0 0 0 0 X 14 13 0 0 0 0 0 0 0 1 1 0 1 1 1 1 1 1 1 1 1 1 0 AL AK AZ AR CA CO CT DE DC FL GA ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY HI X X SUZANNE NEUMAN VP-FINANCE & FINANCIAL STRATEGY 3107250025 1500 ROSECRANS AVENUE NO 200 MANHATTAN BEACH CA 90266 JULIE FLESHMAN PRESIDENT & CEO / DIRECTOR 50.00 X X 770347 0 34545 HILARIE KOPLOW-MC ADAMS CHAIRMAN 2.00 X X 0 0 0 KAREN YOUNG CPA VICE CHAIRMAN 2.00 X X 0 0 0 PETER CASHION BOARD MEMBER 2.00 X 0 0 0 DENNIS CRONIN BOARD MEMBER 2.00 X 0 0 0 SCOTT A GRISWOLD CPA BOARD MEMBER 2.00 X 0 0 0 BARBARA J KENNER PHD BOARD MEMBER 2.00 X 0 0 0 MICHAEL AG KORENGOLD BOARD MEMBER 2.00 X 0 0 0 JASON KUHN BOARD MEMBER 2.00 X 0 0 0 LISA KULOK BOARD MEMBER 2.00 X 0 0 0 TERRENCE MECK BOARD MEMBER 2.00 X 0 0 0 CRAIG A ROGERSON BOARD MEMBER 2.00 X 0 0 0 NANCY STAGLIANO PHD BOARD MEMBER 2.00 X 0 0 0 ROD WILLIAMS MBA BOARD MEMBER 2.00 X 0 0 0 THOMAS CROAL CFO 50.00 X 337191 0 34530 LYNN MATRISIAN CHIEF SCIENCE OFFICER 50.00 X 326605 0 21687 SUDHEER DOSS CHIEF DATA OFFICER 50.00 X 367482 0 22347 LORI STEVENS CHIEF DEVELOPMENT & COMMUNITY ENGAGEMENT OFFICER 50.00 X 304904 0 21915 EDWINA MOSSETT CHIEF PEOPLE OFFICER 50.00 X 279981 0 17317 CHRISTINE DITTMER VICE PRESIDENT, NATIONAL LEADERSHIP GIVING 50.00 X 275352 0 18857 JODI LIPE CHIEF MARKETING OFFICER 50.00 X 264878 0 22293 RICHARD LEONARD NATIONAL DIRECTOR, LEADERSHIP GIVING 50.00 X 247102 0 20419 VICTORIA MANAX FORMER (THRU 2/14/20) 50.00 X 182986 0 4483 3356828 0 218393 45 1 1 0 COVANCE INC 210 CARNEGIE CENTER PRINCETON NJ 08540 CRO SERVICES 5071405 TARGET MARKE TEAM 1200 ABERNATHY RD NE SUITE 1600 ATLANTA GA 30328 DIRECT RESPONSE CAMPAIGNS 755012 THE UNIVERSITY OF TEXAS MD ANDERSON CA PO BOX 4390 HOUSTON TX 77030 CLINICAL RESEARCH 752761 BERRY CONSULTANTS LLC 3345 BEE CAVES RD SUITE 201 AUSTIN TX 78746 PRECISION PROMISE OPERATIONAL AND STATS 612910 UNIVERSITY OF ROCHESTER OFFICE OF RESEARCH ACCOUNTING AND C ROCHESTER NY 14611 CLINICAL RESEARCH 590755 42 181928 9567880 26542891 974001 36292699 PRECISION PROMISE PSS-THROUGH & P 900099 5105747 5105747 PRECISION PROMISE PROGRAM FEE 900099 2224716 2224716 7330463 697700 697700 14681180 13921556 759624 759624 759624 0 9567880 246325 -246325 -246325 44594 26217 18377 18377 44852538 7348840 0 1210999 X 3229138 3229138 1910213 1349426 253442 307345 14277091 10077953 1897387 2301751 484203 345769 62744 75690 993248 709277 128707 155264 1107390 790787 143497 173106 173148 144081 13346 15721 37700 31371 2906 3423 268448 268448 171457 171457 13480722 12401929 182394 896399 564966 504147 20522 40297 258275 198127 8244 51904 970751 668661 146499 155591 957352 678768 127762 150822 71597 64129 561 6907 175045 171924 3121 480118 430145 22888 27085 213619 182867 14091 16661 BANK AND PROCESSING FEE 684534 471733 108409 104392 STAFF SUPPORT 188603 109124 62135 17344 MISCELLANEOUS 130097 64575 14394 51128 EQUIPMENT AND MAINTENAN 46687 33114 6207 7366 12217 10139 939 1139 40886619 32935632 3391652 4559335 1429770 78355 17740483 21067523 15248869 11854561 1382434 1613670 62375 44260 1169049 1007398 5641330 4952004 888066 689326 22769727 31568624 163497 163815 60854270 68087532 3741994 7169708 11394999 7618348 0 971345 1950000 1950000 514647 890226 17601640 18599627 X 27275504 40871033 15977126 8616872 43252630 49487905 60854270 68087532 X 3965919 2206886 62470 X 0 1 X 1 0 X 35758286 53040826 41998701 35529596 36292699 202620108 35758286 53040826 41998701 35529596 36292699 202620108 34500277 168119831 423003 553922 887064 907982 697700 3469671 14854 450 20400 35704 206125483 9968718 0.81560 0.78880 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 109672 158776 268448 37249407 37517855 1000000 250000 0 0 1000000 1000000 1000000 1000000 4000000 6000000 16895 232229 98429 268448 616001 250000 250000 250000 250000 1000000 1500000 6870 59150 4939 109672 180631 SCHEDULE C, PART II-A OFFICE IN WASHINGTON DC ENGAGES IN DEVELOPING REPORT LANGUAGE FOR APPROPRIATIONS BILLS; DEVELOPING ALERTS TO OUR MEMBERS REGARDING SPECIFIC LEGISLATION; PREPARING FOR AND ATTENDING VISITS ON CAPITAL HILL BY OUR MEMBERS AND THE PUBLIC DURING ADVOCACY DAYS; GIVING UNINVITED AND INVITED TESTIMONY OR WRITTEN RESPONSES DURING LEGISLATIVE HEARINGS; DEVELOPING GENERAL EDUCATION MESSAGES THROUGH MEDIA CAMPAIGNS THAT DO OR DO NOT INCLUDE A CALL FOR ACTION. 872026 803186 68840 1391362 1107620 283742 3377942 3041198 336744 689326 CAPITAL LEASE OBLIGATIONS 26340 DEFERRED LEASE LIABILITY 863886 890226 X 46887967 2206886 2206886 44681081 171457 171457 44852538 40652692 -62470 -62470 40715162 171457 171457 40886619 PART X, LINE 2: FIN 48: THE ORGANIZATION IS EXEMPT FROM INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND APPLICABLE STATE LAWS. IN DECEMBER 2017, THE TAX CUTS AND JOBS ACT (THE ACT) WAS ENACTED, WHICH MAY RESULT IN ADDITIONAL UNRELATED BUSINESS TAXABLE INCOME ON CERTAIN FRINGE BENEFITS. THE ORGANIZATION RECOGNIZES THE FINANCIAL STATEMENT BENEFIT OF TAX POSITIONS, SUCH AS FILING STATUS OF TAX-EXEMPT, ONLY AFTER DETERMINING THAT THE RELEVANT TAX AUTHORITY WOULD MORE LIKELY THAN NOT SUSTAIN THE POSITION FOLLOWING AN AUDIT. THE ORGANIZATION HAD NO MATERIAL NET UNRELATED BUSINESS INCOME REQUIRING RECOGNITION FOR THE YEARS ENDED JUNE 30, 2021 AND 2020. THE ORGANIZATION IS SUBJECT TO POTENTIAL INCOME TAX AUDITS ON OPEN TAX YEARS BY ANY TAXING JURISDICTION IN WHICH IT OPERATES. THE STATUTE OF LIMITATIONS FOR FEDERAL AND CALIFORNIA STATE PURPOSES IS GENERALLY THREE AND FOUR YEARS, RESPECTIVELY. PART XII, LINE 2D - OTHER ADJUSTMENTS: RETURN OF UNUSED RESEARCH GRANTS -62,470. WALKS AND RUNS 9567880 9567880 246325 9567880 9567880 246325 246325 -246325 SCHEDULE G, PART I, LINE 3 THE ORGANIZATION IS REGISTERED TO FUNDRAISE IN EVERY STATE. IN FISCAL YEAR 2021, THE PROPER STATE REGISTRATION FORMS WERE FILED. 1 WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY 1300 YORK AVENUE NEW YORK NY 10065 131623978 501(C)(3) 200000 FUND RESEARCH OREGON HEALTH & SCIENCE UNIVERSITY 3181 SW SAM JACKSON PARK ROAD PORTLAND OR 97239 931176109 501(C)(3) 200000 FUND RESEARCH FOX CHASE CANCER CENTER 333 COTTMAN AVENUE PHILADELPHIA PA 191112434 236296135 501(C)(3) 350000 FUND RESEARCH THOMAS JEFFERSON UNIVERSITY 1015 WALNUT STREET CURTIS 618 PHILADELPHIA PA 19107 231352651 501(C)(3) 200000 FUND RESEARCH THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 104 AIRPORT DRIVE CB 1350 CHAPEL HILL NC 275991350 566001393 501(C)(3) 200000 FUND RESEARCH SEATTLE CHILDREN'S RESEARCH INSTITUTE 1100 OLIVE WAY SEATTLE WA 98101 910564748 501(C)(3) 200000 FUND RESEARCH WORCESTER POLYTECHNIC INSTITUTE 100 INSTITUTE ROAD WORCESTER MA 01609 042121659 501(C)(3) 200000 FUND RESEARCH DANA-FARBER CANCER INSTITUTE 450 BROOKLINE AVENUE SM552A BOSTON MA 02215 042263040 501(C)(3) 150000 FUND RESEARCH FRED HUTCHINSON RESEARCH CENTER 1100 FAIRVIEW AVENUE N SEATTLE WA 98109 237156071 501(C)(3) 500000 FUND RESEARCH THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 3451 WALNUT STREET P-221 FB PHILADELPHIA PA 19104 231352685 501(C)(3) 200000 FUND RESEARCH DANA-FARBER CANCER INSTITUTE 450 BROOKLINE AVENUE BOSTON MA 022155450 042263040 501(C)(3) 189549 EARLY DETECTION INITIATIVE SOUTHERN CALIFORNIA PERMANENTE MEDICAL GROUP 2706 MEDIA CENTER DRIVE LOS ANGELES CA 900651733 951750445 PARTNERSHIP 372863 EARLY DETECTION INITIATIVE MASSACHUSETTS GENERAL HOSPITAL 185 CAMBRIDGE STREET BOSTON MA 02114 042697983 501(C)(3) 226726 EARLY DETECTION INITIATIVE BAYLOR COLLEGE OF MEDICINE ONE BAYLOR PLACE HOUSTON TX 770303411 741613878 501(C)(3) 40000 EARLY DETECTION INITIATIVE 13 1 PART I, LINE 2: THE PANCREATIC CANCER ACTION NETWORK ADMINISTERS ITS RESEARCH GRANTS PROGRAM, IN HOUSE. THE AMOUNT OF THE GRANTS AND ELIGIBILITY CRITERIA ARE DETERMINED BY THE ORGANIZATION'S SCIENTIFIC ADVISORY BOARD IN ADVANCE OF PUBLIC NOTIFICATION OF GRANT AVAILABILITY. GRANTS ARE SELECTED BY SCIENTIFIC REVIEW PERFORMED BY A PANEL OF PEER EXPERTS. ALL GRANT AMOUNTS, ELIGIBILITY CRITERIA, AND REVIEW PROCESSES ARE DOCUMENTED ANNUALLY IN THE INDIVIDUAL GRANT APPLICATION PROCEDURE DOCUMENTS. GRANT AMOUNTS AND REVIEW PROCESSES ARE SPECIFIED IN THE GRANT AGREEMENT BETWEEN THE GRANTEE'S INSTITUTION AND THE ORGANIZATION. PROGRESS REPORTS ARE REQUIRED FOR ALL GRANTS AWARDED - TWICE YEARLY. THESE PROGRESS REPORTS ARE COLLECTED BY THE GRANTS ASSOCIATE DIRECTOR AND DOCUMENTED IN THE INDIVIDUAL GRANT POST AWARD FILES. PROGRESS REPORTS INCLUDE A DESCRIPTION OF THE RESEARCH WORK ACCOMPLISHED, FUNDS USED, LESSONS LEARNED AND OTHER OUTCOMES. FINAL REPORTS ARE DUE WITHIN TWO MONTHS OF THE COMPLETION OF THE GRANT PERIOD AND MUST ACCOUNT FOR THE ENTIRE GRANT AMOUNT. THE PANCREATIC CANCER ACTION NETWORK PROGRAM ASSOCIATE DIRECTOR REVIEWS ALL PROGRESS AND FINAL REPORTS. ANNUAL REPORTS ARE ALSO EVALUATED BY MEMBERS OF THE SCIENTIFIC ADVISORY COMMITTEE THAT DETERMINED FUNDING DECISIONS. PROGRAM ASSOCIATE DIRECTOR OR SENIOR MANAGER COMMUNICATES DIRECTLY WITH GRANT RECIPIENTS TO RESOLVE QUESTIONS OR DISCREPANCIES. THIS PROCESS IS DOCUMENTED IN THE GRANT AGREEMENT BETWEEN THE GRANTEE INSTITUTION AND THE ORGANIZATION. THE PANCREATIC CANCER ACTION NETWORK HAS ESTABLISHED OTHER GRANT AGREEMENTS TO FUND SCIENTIFIC INITIATIVES IN CLINICAL TRIALS RESEARCH AND EARLY DETECTION OF PANCREATIC CANCER. SCHEDULE I, PART II GRANTS REPORTED ON SCHEDULE I, PART II ARE GREATER THAN GRANTS REPORTED ON FORM 990, PART IX, LINE 1 DUE TO PRIOR YEAR GRANT REFUNDS. FORM 990, PART IX, LINE 1 IS A NET AMOUNT OF CURRENT YEAR GRANTS AND PRIOR YEAR GRANT REFUNDS. SCHEDULE I, PART II TOTAL GRANTS 3,229,138 ------------- FORM 990, PART IX, LINE 1 GRANTS 3,229,138 X X X X X X 1 1 0 1 0 0 0 0 0 JULIE FLESHMAN PRESIDENT & CEO / DIRECTOR 407684 0 85163 0 277500 0 11239 0 23306 0 804892 0 0 0 SUDHEER DOSS CHIEF DATA OFFICER 324020 0 43462 0 0 0 11248 0 11099 0 389829 0 0 0 THOMAS CROAL CFO 306600 0 30591 0 0 0 11224 0 23306 0 371721 0 0 0 LYNN MATRISIAN CHIEF SCIENCE OFFICER 296840 0 29765 0 0 0 11200 0 10487 0 348292 0 0 0 LORI STEVENS CHIEF DEVELOPMENT & COMMUNITY ENGAGE 258134 0 46770 0 0 0 10816 0 11099 0 326819 0 0 0 EDWINA MOSSETT CHIEF PEOPLE OFFICER 254365 0 25616 0 0 0 9400 0 7917 0 297298 0 0 0 CHRISTINE DITTMER VICE PRESIDENT, NATIONAL LEADERSHIP 247552 0 27800 0 0 0 10000 0 8857 0 294209 0 0 0 JODI LIPE CHIEF MARKETING OFFICER 239633 0 25245 0 0 0 11210 0 11083 0 287171 0 0 0 RICHARD LEONARD NATIONAL DIRECTOR, LEADERSHIP GIVING 220490 0 26612 0 0 0 9400 0 11019 0 267521 0 0 0 VICTORIA MANAX FORMER (THRU 2/14/20) 51773 0 0 0 131213 0 1657 0 2826 0 187469 0 0 0 PART I, LINES 4A-B LINE 4A: THE FOLLOWING INDIVIDUAL RECEIVED A SEVERANCE PAYMENT DURING FISCAL YEAR ENEDED JUNE 30, 2020: VICTORIA MANAX $131,213 LINE 4B: THE FOLLOWING INDIVIDUAL PARTICIPATES IN A NON-QUALIFIED TAXABLE RETIREMENT PLAN OF THE ORGANIZATION: JULIE FLESHMAN $250,000 PART I, LINE 5 THE PERFORMANCE INCENTIVE PLAN INCENTIVIZES OUR VALUED TEAM MEMBERS IF CERTAIN REVENUE ACHIEVEMENTS ARE REACHED. X 8000 FMV X 42 965851 FMV X GIFT CARD 1 150 FMV 0 1 0 SCHEDULE M, PART I, COLUMN (B): THE NUMBER IN COLUMN (B) REPRESENTS THE NUMBER OF CONTRIBUTIONS. FORM 990, PART VI, SECTION B, LINE 11B THE AUDIT AND INVESTMENT COMMITTEE ("AIC") RECEIVES AND REVIEWS THE DRAFT OF THE FORM 990, INCLUDING SCHEDULES, PRIOR TO THE FILING OF THE RETURN. A MEETING OF THE AIC, INCLUDING THE PRESIDENT AND CEO, VP OF FINANCE, THE CFO, THE CONTROLLER, AND THE OUTSIDE CPA FIRM, IS THEN HELD TO REVIEW AND REVISE AS NECESSARY THE DRAFT OF THE FORM 990. UPON APPROVAL OF THE DRAFT FORM 990 BY THE AIC, THE FINAL FORM 990, WITH CHANGES REFLECTED, IF ANY, IS E-MAILED TO THE ENTIRE BOARD OF DIRECTORS PRIOR TO FILING FOR ITS REVIEW. UPON ITS APPROVAL, THE FINAL FORM 990 IS FILED ELECTRONICALLY. FORM 990, PART VI, SECTION B, LINE 12C THE BOARD OF DIRECTORS IS REQUIRED TO SUBMIT AN UPDATED CONFLICT OF INTEREST STATEMENT ON AN ANNUAL BASIS. TO THE EXTENT THAT RELATIONSHIPS ARE IDENTIFIED VIA THESE STATEMENTS AND OTHER INFORMATION, THE INDIVIDUAL'S CONSTITUENT RECORD IN THE COMPANY DATA BASE IS UPDATED TO INCLUDE THIS INFORMATION, FACILITATING PERIODIC QUERIES, AS NECESSARY. THE MEMBER WITH A CONFLICT MUST IDENTIFY THE CONFLICT AT ANY BOARD MEETING WHERE THE CONFLICT IS RELEVENT. THE MEMBER CANNOT BE PRESENT AT ANY PART OF THE MEETING WHERE THE RELEVENT TOPIC IS DISCUSSED OR VOTED ON. THE MEMBER CANNOT BE COUNTED FOR A QUORUM. FORM 990, PART VI, SECTION B, LINE 15 THE BOARD COMPENSATION COMMITTEE IS RESPONSIBLE FOR THE ANNUAL REVIEW AND APPROVAL OF THE COMPENSATION FOR TOP-LEVEL EXECUTIVE MANAGEMENT, OFFICERS, AND KEY EMPLOYEES. THE CHIEF PEOPLE OFFICER STAYS ABREAST OF INDUSTRY SALARY LEVELS AND ALERTS THE COMMITTEE TO ANY CHANGE IN SALARY LEVELS. INDEPENDENT PROFESSIONAL EXPERTS ARE CALLED UPON FOR HIGHER-LEVEL POSITIONS AND ASSIST IN ESTABLISHING EXECUTIVE SALARIES IN THE COMPETITIVE MARKETPLACE. SALARIES IN BOTH FOR PROFIT AND NOT FOR PROFIT ORGANIZATIONS ARE EVALUATED IN ORDER TO ATTRACT THE MOST TALENTED PERSONNEL. INFORMATION IS GATHERED, ANALYZED AND REPORTED TO THE COMMITTEE PRIOR TO THEIR MEETINGS ON COMPENSATION WITH THE INTENT OF ENSURING THAT THE EXECUTIVE COMPENSATION PROGRAM FALLS WITHIN A REASONABLE RANGE OF COMPETITIVE PRACTICES FOR COMPARABLE POSITIONS AMONG SIMILARLY SITUATED ORGANIZATIONS. THE REVIEW INCLUDES INCENTIVE PLANS AND ALL FRINGE BENEFITS AS WELL AS BASE SALARY ARRANGEMENTS. THE BOARD ESTABLISHES THE CEO/PRESIDENT SALARY LEVEL DURING THE EXECUTIVE SESSION OF A CALLED BOARD MEETING. ONCE APPROVED, EXECUTIVE COMPENSATION PACKAGES ARE FORMALIZED IN WRITING AND ONCE ACCEPTED BY THE EXECUTIVE, RETAINED IN THE EXECUTIVES' PERSONNEL FILE(S). FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION HAS A FORMAL POLICY FOR PUBLIC DISCLOSURE AND INSPECTION OF DOCUMENTS. THE POLICY IS POSTED ON THE ORGANIZATION'S WEB-SITE. FORM 990, PART IX, LINE 11G CLINICAL RESEARCH: PROGRAM SERVICE EXPENSES 11,325,103. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 11,325,103. PROFESSIONAL FEES - RECRUITMENT AND HR: PROGRAM SERVICE EXPENSES 43,285. MANAGEMENT AND GENERAL EXPENSES 5,869. FUNDRAISING EXPENSES 28,842. TOTAL EXPENSES 77,996. PROFESSIONAL FEES - TECHNOLOGY: PROGRAM SERVICE EXPENSES 169,609. MANAGEMENT AND GENERAL EXPENSES 22,996. FUNDRAISING EXPENSES 113,016. TOTAL EXPENSES 305,621. PROFESSIONAL FEES - PAYROLL AND ADMINISTRATION: PROGRAM SERVICE EXPENSES 13,122. MANAGEMENT AND GENERAL EXPENSES 1,779. FUNDRAISING EXPENSES 8,743. TOTAL EXPENSES 23,644. PROFESSIONAL FEES - 401K AUDIT: PROGRAM SERVICE EXPENSES 10,808. MANAGEMENT AND GENERAL EXPENSES 1,465. FUNDRAISING EXPENSES 7,202. TOTAL EXPENSES 19,475. PROFESSIONAL FEES - OTHER: PROGRAM SERVICE EXPENSES 840,002. MANAGEMENT AND GENERAL EXPENSES 150,285. FUNDRAISING EXPENSES 738,596. TOTAL EXPENSES 1,728,883. FORM 990, PART XI, LINE 9: RETURN OF UNUSED RESEARCH GRANTS 62,470. FORM 990 PART VI, LINE 10B COMPANY "AFFILIATES" CONSIST OF VOLUNTEERS WHO AGREE TO PERFORM THEIR VOLUNTEER ACTIVITIES IN COMPLIANCE WITH GUIDELINES PROVIDED IN A COMMUNITY ENGAGEMENT AFFILIATE AGREEMENT. THERE ARE NO NON-VOLUNTEER AFFILIATES, CHAPTERS OR BRANCHES (E.G., NO LEGAL ENTITIES). FORM 990, PART VIII, LINE 8C THE PANCREATIC CANCER ACTION NETWORK AND THEIR NETWORK OF VOLUNTEER AFFILIATES HELD WALKS, RUNS, AND BIKE EVENTS ALL OVER THE NATION TO BOTH FUNDRAISE AND RAISE PUBLIC AWARENESS ABOUT PANCREATIC CANCER. ALL REVENUE RAISED FROM THE EVENTS ARE CONSIDERED TO BE CHARITABLE CONTRIBUTIONS. THE ENTITY DOES INCUR EXPENSES IN CONDUCTING THE EVENTS, BUT BECAUSE ALL INCOME IS CATEGORIZED AS CONTRIBUTION REVENUE, IT IS REPORTED AS A LOSS FROM SPECIAL EVENTS, EVEN THOUGH THE EVENT WAS PROFITABLE.